Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy.

Mol Cancer · 2023 · PMC10640763 · PMID 37951964

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Allo-HCT2 has achieved long-term remission in about 30% of patients [ 154 – 158 ], and showed a trend for improvement over time [ 159 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.